Skip to main navigation Skip to search Skip to main content

An Open Label Study Evaluating the Safety and Efficacy of Long Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Throbocytopenic Purpura (ITP)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/13/07 → 08/31/10

Funding

  • Amgen Incorporated: $18,088.13